GRAIL, LLC
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. The compan… Read more
GRAIL, LLC (GRAL) - Total Liabilities
Latest total liabilities as of December 2025: $344.15 Million USD
Based on the latest financial reports, GRAIL, LLC (GRAL) has total liabilities worth $344.15 Million USD as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
GRAIL, LLC - Total Liabilities Trend (2018–2025)
This chart illustrates how GRAIL, LLC's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
GRAIL, LLC Competitors by Total Liabilities
The table below lists competitors of GRAIL, LLC ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Adient PLC
NYSE:ADNT
|
USA | $6.80 Billion |
|
Yealink Network Technology Corp Ltd
SHE:300628
|
China | CN¥1.11 Billion |
|
Muenchener Rueckver Ges
PINK:MURGY
|
USA | $246.71 Billion |
|
Hella KGaA Hueck & Co
XETRA:HLE
|
Germany | €4.17 Billion |
|
Unicaja Banco S.A
PINK:UNJCF
|
USA | $91.30 Billion |
|
Hang Zhou Iron & Steel Co Ltd
SHG:600126
|
China | CN¥13.92 Billion |
|
Mitie Group plc
PINK:MITFF
|
USA | $2.05 Billion |
Liability Composition Analysis (2018–2025)
This chart breaks down GRAIL, LLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 11.97 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.13 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.12 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how GRAIL, LLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for GRAIL, LLC (2018–2025)
The table below shows the annual total liabilities of GRAIL, LLC from 2018 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $344.15 Million | -28.29% |
| 2024-12-31 | $479.90 Million | -47.31% |
| 2023-12-31 | $910.74 Million | -4.73% |
| 2022-12-31 | $955.94 Million | +210.98% |
| 2021-12-31 | $307.40 Million | +112.79% |
| 2020-12-31 | $144.46 Million | +69.97% |
| 2019-12-31 | $84.99 Million | -1.71% |
| 2018-12-31 | $86.47 Million | -- |